Metapause
Metapause operates a US-based AI health concierge platform (ELSA) that delivers personalized menopause and longevity protocols, symptom tracking, and telehealth access to women navigating perimenopause and beyond. Revenue comes from subscriptions and clinician consultations, delivered direct-to-consumer.
- Company typePrivate
- Founded2023
- HeadquartersMiami, United States
- Headcount1–10
- GTM typeB2C
- OfferingSoftware
What Metapause does
MetaPause is a US-based women's health technology company, incorporated as Metapause LLC in New York and headquartered in Miami, that operates an AI-powered platform focused on perimenopause, menopause, and post-menopause. The platform targets women navigating hormonal transitions as well as women in their 30s and 40s seeking proactive longevity management, offering symptom tracking across hot flashes, sleep, mood, cognition, and related concerns, alongside a proprietary AI concierge named ELSA that ingests labs, wearables, genetics, and self-reported symptoms to produce a longitudinal "Meta Score" and personalized protocols covering supplements, peptides, hormones, and lifestyle interventions. Recommendations are vetted by a council of physicians, OBGYN/integrative wellness experts, longevity specialists, and nutritionists, and the company layers telehealth video consultations with certified clinicians and a community feature for peer support on top of the core app.
The product is delivered via a web and mobile application to a direct-to-consumer audience through a self-serve, waitlist-gated onboarding flow. Revenue mechanics combine a subscription access model with paid telehealth consultations; no pricing tiers are publicly disclosed. Distribution is primarily digital — Substack newsletter, website waitlist, LinkedIn presence, and customer testimonials — and the company cites HIPAA-compliant data handling with no sale of personal health data. Founded in 2023 with a team of 1–10, MetaPause is privately held and founder-controlled (CEO Lauren Weiniger, CTO Kirk McMurray) with no disclosed institutional funding rounds to date.
Operationally the company is at a pre-scale commercialization stage: it is registered as a peptide therapy provider in New York and New Jersey, but has no app store links, no disclosed revenue or ARR, and no named enterprise customers. Customer evidence consists of three named individual testimonials. The combined signal points to an early-launch, consumer-direct model rather than an established revenue base.
Metapause firmographics
Firmographics- Name
- Metapause
- Legal name
- Metapause LLC
- Website
- https://themetapause.com
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Metapause operates a US-based AI health concierge platform (ELSA) that delivers personalized menopause and longevity protocols, symptom tracking, and telehealth access to women navigating perimenopause and beyond. Revenue comes from subscriptions and clinician consultations, delivered direct-to-consumer.
- Ownership category
- akta.pro rank
Metapause industry classification
Industry- Product category
- Women's Health and Menopause Platform
- NAICS
- Home Health Care Services (62161)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Medical Wellness & Longevity (Health Screening, Biohacking, Anti-aging Programs) (THAJAHAI)
- akta.pro secondary industries
- Geriatric, Frailty & Fall-Prevention Remote Monitoring (HLALAFAI), Health, Wellness & Patient Communities (MPACAJAL)
Keywords
Where Metapause is headquartered
LocationHeadquarters
- HQ city
- Miami
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Metapause business model
Business model- GTM type
- B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Platform Subscription: Subscription-based access to the AI health concierge app, personalized protocols, symptom tracking, and community features. Users can register via waitlist for access.
- Telehealth Consultations: Video consultations with certified clinicians and longevity experts available through the platform for personalized medical guidance
Go-to-market motion3 records
Distribution channels3 records
Marketing channels4 records
Metapause product offering
Product offeringCore offering
MetaPause is a personalized AI-powered health and longevity platform designed for women navigating perimenopause, menopause, and post-menopause. The platform combines an in-house AI health concierge (ELSA) that integrates user labs, wearables, genetics, and symptoms, with personalized protocol matching to vetted supplements, peptides, hormones, and lifestyle interventions. It also offers telehealth consultations with clinicians and a peer community for women in midlife health transitions.
Product overview
MetaPause is a unified personalized health and longevity platform designed to support women through perimenopause, menopause, and beyond. The platform combines multiple integrated features: the core MetaPause platform serves as the main interface, powered by ELSA—an in-house AI health concierge that connects user data (labs, wearables, genetics, symptoms) to generate personalized insights and the Meta Score. Users receive Personalized Protocols matching them to vetted supplements, peptides, hormones, and lifestyle recommendations. The Symptom Tracker with Meta Score enables tracking of symptom severity and trends over time. Telehealth Expert Consultations provide access to clinically trained longevity experts via video calls, while the Women Community feature enables peer support and shared learning. All recommendations are grounded in scientific research and vetted by a council of physicians and longevity experts.
Differentiator
Problem solved
Functional benefit
Products and services
- MetaPause Platform A personalized health and longevity platform supporting women through perimenopause, menopause, and beyond with evidence-based tools, symptom tracking, AI-powered guidance, expert telehealth consultations, and community support.
- ELSA AI Health Concierge In-house AI that asks smart questions and connects user data including labs, wearables, genetics, and symptoms to generate personalized health insights and track progress via the Meta Score.
- Personalized Protocols Matched recommendations for vetted supplements, peptides, hormones, and lifestyle shifts tailored to individual user profiles and health situations.
- Symptom Tracker and Meta Score Tracks symptoms (hot flashes, sleep, mood, cognition) and generates a menopause score to help users track severity and improvements over time with trend visualization.
- Telehealth Expert Consultations Video call sessions with MetaPause's clinically trained longevity experts and certified clinicians to provide personalized health guidance.
- Women Community Community feature connecting likeminded women to share experiences and learn from each other's menopause journeys.
Quantifiable outcome
- Menopause score tracking to measure symptom severity and improvements over time
Companies that use Metapause
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles2 records
Metapause technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature4 records
Metapause partnerships and signals
Strategic signalScale indicators1 record
Recent moves6 records
Expansion highlights4 records
Metapause competitors and assessment
Company assessmentDirect peers
- Evernow: Telehealth provider for menopause care offering clinician consultations and ongoing treatment plans. Overlaps with MetaPause's clinical services and personalization layer for midlife women.
- Midi Health: Virtual care clinic focused on perimenopause and menopause with clinician-led visits and ongoing care plans. Closest direct peer in target demographic, clinical model, and subscription/visit revenue structure.
- Elektra Health: Digital menopause care platform combining telehealth, evidence-based education, and a community. Directly comparable to MetaPause's integrated AI + clinician + community stack targeting the same ICP.
- Gennev: Menopause-focused telemedicine and education platform with on-demand clinician access. Comparable to MetaPause's combination of telehealth, content, and perimenopause/menopause support.
- Alloy Women's Health: Direct-to-consumer menopause care offering telehealth consultations, prescriptions, and supplements. Comparable business model with overlapping protocol-and-product monetization.
- Winona: Menopause-focused telehealth platform offering clinician consultations and hormone-related treatments. Mirrors MetaPause's emphasis on vetted hormone/peptide protocols and clinician access.
- HerMD: Women's health provider combining in-person and virtual care for menopause and sexual health. Comparable women's midlife health focus with hybrid clinical model.
Broad incumbents
- Maven Clinic: Largest women's and family health virtual clinic with broad coverage beyond menopause. Serves as a broad incumbent showing the scaled version of MetaPause's virtual specialty model.
- Tia: Women's healthcare provider blending virtual and in-person primary care with specialty services including menopause. Comparable care philosophy and women's health focus at a larger scale.
Emerging players
- Parsley Health: Integrative medicine platform pairing clinicians with tech-enabled care plans for women's health and longevity. Comparable 'root-cause' functional-medicine approach and longevity/wellness overlap with MetaPause.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Metapause social profiles
Digital presenceMetapause compliance and trust
Trust signalCompliance1 record
Metapause financial estimates
Financial estimateRevenue estimate
Valuation estimate
Metapause leadership team
Management profileNumber of profiles
Profiles10 records
Metapause funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Metapause M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Metapause
What does Metapause do?
MetaPause is a personalized AI-powered health and longevity platform designed for women navigating perimenopause, menopause, and post-menopause. The platform combines an in-house AI health concierge (ELSA) that integrates user labs, wearables, genetics, and symptoms, with personalized protocol matching to vetted supplements, peptides, hormones, and lifestyle interventions. It also offers telehealth consultations with clinicians and a peer community for women in midlife health transitions.
Is Metapause a public or private company?
Metapause is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Metapause founded?
Metapause was founded in 2023. It employs 1 to 10 people.
Where is Metapause based?
Metapause is headquartered in Miami, United States, in the North America region.
How does Metapause make money?
Two revenue lines are on record. Platform Subscription is the primary driver. The others are telehealth Consultations.
Who are Metapause's main competitors?
Direct peers on record are Evernow, Midi Health, Elektra Health, Gennev, Alloy Women's Health, Winona and HerMD. Broad incumbents are Maven Clinic and Tia. Parsley Health is listed as an emerging player.
Does Metapause have an API?
No public API is recorded for Metapause.
What industry is Metapause in?
Metapause's product category is Women's Health and Menopause Platform. Its primary akta.pro industry code is THAJAHAI, Medical Wellness & Longevity (Health Screening, Biohacking, Anti-aging Programs), with a secondary code of HLALAFAI, Geriatric, Frailty & Fall-Prevention Remote Monitoring. Its NAICS code is 62161 and its SIC code is 7372.